🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 63 of 200 · A–Z by INN

  1. elacestrant

    ORSERDU

    EMA: approved

    L02BA

  2. elacestrant hydrochloride

    ORSERDU

    ORAL FDA: approved

  3. eladocagene exuparvovec

    UPSTAZA

    EMA: approved

    A16AB26

  4. elafibranor

    IQIRVO Ipsen

    ORAL FDA: approved · EMA: approved · TGA: approved

    A05AX06

  5. elagolix

    ELAGOLIX Teva Pharma GmbH

    FILM COATED FDA: approved

  6. elagolix sodium

    ORILISSA

    ORAL FDA: approved

  7. elagolix sodium,estradiol,norethindrone acetate

    ORIAHNN (COPACKAGED)

    ORAL FDA: approved

  8. elagolix, estradiol and norethindrone acetate and elagolix

    SHEUR Teva Pharma GmbH

    FDA: approved

  9. elamipretide hydrochloride

    FORZINITY

    SUBCUTANEOUS FDA: approved

  10. elapegademase

    REVCOVI

    PMDA: approved

  11. elapegademase-lvlr

    REVCOVI

    INJECTION FDA: approved

  12. elbasvir

    ZEPATIER

    ORAL FDA: approved · EMA: approved · PMDA: approved

    J05AP54

  13. eletriptan

    RELPAX Viatris Pharmaceuticals Co.,

    TGA: approved

  14. eletriptan hydrobromide

    ELETRIPTAN HYDROBROMIDE Teva Pharma GmbH

    ORAL FDA: approved

  15. elexacaftor, ivacaftor, tezacaftor

    TRIKAFTA (COPACKAGED) Vertex Pharmaceuticals (Australia) Pty.

    ORAL FDA: approved

  16. eliglustat

    CERDELGA

    EMA: approved

    A16AX10

  17. eliglustat tartrate

    CERDELGA Teva Pharma GmbH

    ORAL FDA: approved · PMDA: approved

  18. elinzanetant

    LYNKUET

    ORAL FDA: approved · EMA: approved

  19. elivaldogene autotemcel

    SKYSONA

    EMA: withdrawn

    N07

  20. elobixibat hydrate

    GOOFICE

    PMDA: approved

  21. eloralintide

    NMPA: clinical trials

  22. elosulfase alfa

    VIMIZIM BioMarin Pharmaceutical Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved

    A16AB12

  23. elotuzumab

    EMPLICITI Bristol-Myers Squibb Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01FX08

  24. elranatamab

    ELREXFIO Pfizer Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources